Archive for March 7th, 2010

The Bank Failure Tally in US Reaches 26 »

Despite the gradual recovery gaining grounds in the U. S. economy, more than 20 banks Maryland, Illinois, Florida and Utah, have been shut down, since this January.

Business Owners Plans to Invest in U.S. Real Estate »

Business owners have been planning to invest in U. S. property.

Due to John Lewis Partnership £140m Bonus to be Offered »

The John Lewis Partnership would result in a bonus of at least £140m to 70,000 staff members.

Common Painkillers Can Encourage Cancer Growth »

According to a new study, common pain killers can result in the growth of cancer cells. Painkillers comprised of Opiate can promote cancer growth.

US judge Puts Apple-Nokia Legal Battle on Hold »

A US federal judge has put the Apple-Nokia legal battle on hold, until the feds get their chance to investigate into the whole matter that seems to have tangled itself to no end.

Google Acquires DocVerse, Targets Microsoft »

Google Inc. stepped up their game yet again, to give Microsoft Corp. a run for its money. In what was Google’s fourth buy under a 30 day time period, the search giant acquired the 3 year old DocVerse on Friday, which allows users to edit their Microsoft Office files online.

Microsoft Holds its Ground despite China-Google Debacle »

Microsoft has stated that it is not looking too much into the recent Google-China debacle, and that it intends to go ahead with its development of the Internet search market in China like usual.

Obese Females at a Higher Risk of Pregnancy Complications »

A recent study has revealed that overweight females are more at risk of pregnancy problems and face a threat of having abnormally large babies.

User Errors Linked with Insulin Pumps »

Members of U. S. Government Advisory Panel reported that more problems were likely to be experienced by the diabetics due to the improper use of insulin pumps as compared to the problems caused due to defects in the device.

U.S. FDA Concerned but InterMune Shares Rise »

Concerns have been raised by the U. S. health regulatory staff about unclear trial results and the possible side effects with InterMune Inc’s drug, Pirfenidone which is used for lung scarring.